(Q44130414)

English

Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery

scientific article published on 26 March 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 November 2017

Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery (English)

1 reference

Europe PubMed Central

30 November 2017

author name string

Yugang Wen

1

1 reference

Europe PubMed Central

30 November 2017

Quan Wang

2

1 reference

Europe PubMed Central

30 November 2017

Chongzhi Zhou

3

1 reference

Europe PubMed Central

30 November 2017

Dongwang Yan

4

1 reference

Europe PubMed Central

30 November 2017

Guoqiang Qiu

5

1 reference

Europe PubMed Central

30 November 2017

Chun Yang

6

1 reference

Europe PubMed Central

30 November 2017

Huamei Tang

7

1 reference

Europe PubMed Central

30 November 2017

Zhihai Peng

8

1 reference

Europe PubMed Central

30 November 2017

publication date

26 March 2011

1 reference

Europe PubMed Central

30 November 2017

Annals of Surgical Oncology

1 reference

Europe PubMed Central

30 November 2017

18

1 reference

Europe PubMed Central

30 November 2017

13

1 reference

Europe PubMed Central

30 November 2017

3858-3867

1 reference

Europe PubMed Central

30 November 2017

https://scigraph.springernature.com/pub.10.1245/s10434-011-1668-5

0 references

Screening for gastric cancer in Asia: current evidence and practice.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

Changing gastric cancer treatment in the United States and the pursuit of quality

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

RASSF6 is a novel member of the RASSF family of tumor suppressors

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

The Ki-67 protein: from the known and the unknown

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

Loss of BMI-1 expression is associated with clinical progress of malignant melanoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

Role of the Ras-association domain family 1 tumor suppressor gene in human cancers

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

Molecular-pathological prognostic factors of gastric cancer: a review

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

The RASSF1A tumor suppressor activates Bax via MOAP-1.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

Haplotype mapping of the bronchiolitis susceptibility locus near IL8.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1668-5

21 January 2018

Identifiers

10.1245/S10434-011-1668-5

1 reference

Europe PubMed Central

30 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44130414&oldid=2106907975"